Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |